Bonuccelli U - Search Results

1

Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders.

Ceravolo R, Frosini D, Rossi C, Bonuccelli U. Ceravolo R, et al. Among authors: bonuccelli u. J Neurol. 2010 Nov;257(Suppl 2):S276-83. doi: 10.1007/s00415-010-5715-0. J Neurol. 2010. PMID: 21080189 Review.

2

Pergolide in the treatment of patients with early and advanced Parkinson's disease.

Bonuccelli U, Colzi A, Del Dotto P. Bonuccelli U, et al. Clin Neuropharmacol. 2002 Jan-Feb;25(1):1-10. doi: 10.1097/00002826-200201000-00001. Clin Neuropharmacol. 2002. PMID: 11852289 Review.

3

Orthostatic hypotension in de novo Parkinson disease.

Bonuccelli U, Lucetti C, Del Dotto P, Ceravolo R, Gambaccini G, Bernardini S, Rossi G, Piaggesi A. Bonuccelli U, et al. Arch Neurol. 2003 Oct;60(10):1400-4. doi: 10.1001/archneur.60.10.1400. Arch Neurol. 2003. PMID: 14568810 Clinical Trial.

4

Comparing dopamine agonists in Parkinson's disease.

Bonuccelli U. Bonuccelli U. Curr Opin Neurol. 2003 Dec;16 Suppl 1:S13-9. doi: 10.1097/00019052-200312001-00004. Curr Opin Neurol. 2003. PMID: 15180133 Review.

5

Dopamine agonists in the treatment of Parkinson's disease.

Bonuccelli U, Pavese N. Bonuccelli U, et al. Expert Rev Neurother. 2006 Jan;6(1):81-9. doi: 10.1586/14737175.6.1.81. Expert Rev Neurother. 2006. PMID: 16466315 Review.

6

Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.

Lucetti C, Gambaccini G, Del Dotto P, Ceravolo R, Logi C, Rossi G, Murri L, Bonuccelli U. Lucetti C, et al. Among authors: bonuccelli u. Parkinsonism Relat Disord. 2006 Jun;12(5):279-83. doi: 10.1016/j.parkreldis.2005.12.005. Epub 2006 Mar 23. Parkinsonism Relat Disord. 2006. PMID: 16549382

7

Association between amantadine and the onset of dementia in Parkinson's disease.

Inzelberg R, Bonuccelli U, Schechtman E, Miniowich A, Strugatsky R, Ceravolo R, Logi C, Rossi C, Klein C, Rabey JM. Inzelberg R, et al. Among authors: bonuccelli u. Mov Disord. 2006 Sep;21(9):1375-9. doi: 10.1002/mds.20968. Mov Disord. 2006. PMID: 16705684

8

New pharmacologic horizons in the treatment of Parkinson disease.

Bonuccelli U, Del Dotto P. Bonuccelli U, et al. Neurology. 2006 Oct 10;67(7 Suppl 2):S30-8. doi: 10.1212/wnl.67.7_suppl_2.s30. Neurology. 2006. PMID: 17030738 Review.

9

How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaire.

Morgante L, Morgante F, Moro E, Epifanio A, Girlanda P, Ragonese P, Antonini A, Barone P, Bonuccelli U, Contarino MF, Capus L, Ceravolo MG, Marconi R, Ceravolo R, D'Amelio M, Savettieri G. Morgante L, et al. Among authors: bonuccelli u. Parkinsonism Relat Disord. 2007 Dec;13(8):528-31. doi: 10.1016/j.parkreldis.2006.12.013. Epub 2007 Mar 7. Parkinsonism Relat Disord. 2007. PMID: 17347021

10

Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.

Kiferle L, Ceravolo R, Petrozzi L, Rossi C, Frosini D, Rocchi A, Siciliano G, Bonuccelli U, Murri L. Kiferle L, et al. Among authors: bonuccelli u. Neurosci Lett. 2007 Jul 18;422(3):228-31. doi: 10.1016/j.neulet.2007.06.028. Epub 2007 Jun 22. Neurosci Lett. 2007. PMID: 17614196

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters